Mesenchymal Stem/Stromal Cells Therapy for Metabolic Syndrome: Potential Clinical Application?

Huang, Xiuyi; Liu, Yunchong; Li, Zilun; Lerman, Lilach O

Huang, Xiuyi; Liu, Yunchong; Li, Zilun; Lerman, Lilach O.

Affiliation

Huang X; Division of Vascular Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
Liu Y; Division of Vascular Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
Li Z; Division of Vascular Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
Lerman LO; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.

Stem Cells ; 41(10): 893-906, 2023 10 08.

Article de En | MEDLINE | ID: mdl-37407022

Sujet(s)
Mots clés

adipose stem cells; clinical translation; diabetes; mesenchymal stem cells; stem cellmicroenvironment interactions; stromal cells

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome métabolique X / Transplantation de cellules souches mésenchymateuses / Cellules souches mésenchymateuses / Vésicules extracellulaires Limites: Humans Langue: En Journal: Stem Cells Année: 2023 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google